Microcystis aeruginosa (Microcystaceae) Blue-Green Alga, Toxic Cyanobacterium

Quick Overview:

Microcystis aeruginosa is a pervasive and ecologically significant freshwater cyanobacterium, notorious for forming harmful algal blooms (HABs) in eutrophic water bodies worldwide. It is most notably recognized as a potent producer of microcystins, a family of hepatotoxins that pose serious threats to human, animal, and environmental health. Despite its toxicity, it is also a subject of intense biotechnological research, yielding a diverse array of bioactive compounds including microginins with potential pharmaceutical applications, such as angiotensin-converting enzyme (ACE) inhibition for hypertension treatment, as well as compounds exhibiting anticancer, antioxidant, and antibacterial properties .

---

1. Taxonomic Insights

Species: Microcystis aeruginosa (Kützing) Kützing

Family: Microcystaceae

Taxonomic Note: The species was first described as Micraloa aeruginosa by Kützing in 1833 and later reclassified. Its nomenclatural history is complex, with multiple synonyms including Diplocystis aeruginosa and Polycystis aeruginosa. The validly published name under the International Code of Nomenclature for algae, fungi, and plants is Microcystis aeruginosa (Kützing 1833) Lemmermann 1907, a conserved name . The etymology is from the Latin aeruginosa, meaning "full of copper rust" or "verdigris," referring to its blue-green color .

The family Microcystaceae comprises colonial cyanobacteria within the order Chroococcales, phylum Cyanobacteria. These organisms are characterized by small, spherical cells that aggregate into colonies, often held together by mucilage. They are prokaryotic bacteria, not algae, performing oxygenic photosynthesis .

Related Organisms from the Same Phylum:

· Microcystis wesenbergii: A closely related species also forming blooms, distinguishable by its distinct colonial mucilage.

· Aphanizomenon flos-aquae: A filamentous cyanobacterium often co-occurring with Microcystis in blooms, capable of producing neurotoxins (anatoxin-a) and cylindrospermopsin .

· Planktothrix rubescens: A filamentous cyanobacterium known for producing microcystins and associated with deep chlorophyll maxima in lakes.

· Nostoc commune: A terrestrial cyanobacterium forming gelatinous colonies, used in traditional medicine and as a food source in some cultures.

---

2. Common Names

Scientific Name: Microcystis aeruginosa Kützing | English: Blue-green alga (misleading, as it is a bacterium), Toxic cyanobacteria | Common Names: No widely established common names; referred to by its genus or as the causative agent of "toxic algal blooms" or "cyanobacterial blooms." | Japanese: ミクロキスティス・アエルギノーザ (Mikurokisutisu aeruginōza) | Chinese: 铜绿微囊藻 (Tóng lǜ wēi náng zǎo) |

---

3. General Characteristics and Ecological Role

Morphology: Cells are spherical, 2 to 6 micrometers in diameter, occurring singly or in pairs in culture, but forming irregular, gelatinous colonies in natural environments . Colonies can become large enough to be visible to the naked eye as greenish particles or scums. Cells contain gas vesicles that provide buoyancy, allowing them to regulate their position in the water column to access optimal light and nutrients .

Metabolism: Photoautotrophic, using light as an energy source and carbon dioxide as a carbon source. They possess phycobiliproteins (phycocyanin) as accessory photosynthetic pigments .

Ecological Niche: Thrives in nutrient-rich (eutrophic) freshwater systems such as lakes, ponds, and slow-moving rivers, particularly in warm conditions with stable water columns. Blooms are favored by warm temperatures (optimal growth around 32°C) and high nutrient inputs, especially phosphorus and nitrogen from agricultural runoff and wastewater .

Global Distribution: Blooms have been reported in at least 108 countries, with microcystin production confirmed in at least 79 . It is a cosmopolitan species, found on every continent except Antarctica, and is the most abundant cyanobacterial genus in South Africa .

---

4. Cyanotoxins and Other Bioactive Compounds

Microcystins (The Signature Hepatotoxins): These are cyclic heptapeptides, with microcystin-LR being the most common and well-studied congener . They are potent inhibitors of protein phosphatases 1 and 2A in eukaryotic cells, leading to disruption of the cytoskeleton, liver cell damage, and tumor promotion . Microcystins are produced by non-ribosomal peptide synthetase enzyme complexes.

Microginins (Linear Pentapeptides with Biotechnological Potential): First discovered in M. aeruginosa, these are linear peptides characterized by the presence of a unique amino acid, 3-amino-2-hydroxydecanoic acid (Ahda), and two tyrosine units at the C-terminus . Their primary known bioactivity is inhibition of angiotensin-converting enzyme (ACE), making them potential leads for antihypertensive drugs. They also inhibit aminopeptidases and exhibit eco-cytotoxic activity against crustaceans and fish larvae . Over 120 distinct microginin structures have been identified.

Other Cyanopeptides: M. aeruginosa produces a wide array of other bioactive peptides including cyanopeptolins (protease inhibitors), aeruginosins (serine protease inhibitors), microviridins (protease inhibitors), and microcyclamides .

Lipopolysaccharides (LPS): Present in the cell wall, these can act as endotoxins and are believed to cause skin irritations and allergic reactions in humans upon contact .

Other Metabolites with Therapeutic Potential: Research has isolated compounds such as benzeneacetanomide and norvaline derivatives from M. aeruginosa biomass, which have demonstrated in vitro antibacterial, antioxidant, and anticancer activities . The cyanobacterium is also a subject of research for the natural production of butylated hydroxytoluene (BHT), an industrial antioxidant .

---

5. Public Health and Environmental Significance

Human Health Risks:

· Recreational Exposure: Contact with blooms can cause minor skin irritations, eye irritation, and blistering of the lips, likely due to lipopolysaccharides. Inadvertent ingestion may lead to abdominal cramps, nausea, vomiting, diarrhea, fever, and sore throat, with recovery typically within 48 hours . Young children are considered at higher risk due to their smaller body mass and vigorous activity in water.

· Drinking Water Contamination: Microcystins are stable and water-soluble, posing a challenge for water treatment. Severe contamination of a drinking water reservoir in Brazil in 1988 caused over 2,000 cases of gastroenteritis with 88 deaths .

· Dialysis Incidents: Fatalities have occurred when microcystin-contaminated water was used for kidney dialysis, underscoring the potent toxicity of these compounds .

· Genotoxicity: A 2024 study demonstrated that methanolic extracts of cyanobacterial biomass containing M. aeruginosa cause significant, dose-dependent DNA damage in human peripheral blood lymphocytes in vitro, with a Genetic Damage Index rising from 0.61 to 2.39 as concentration increased. The same extract also induced concentration-dependent hemolysis of red blood cells .

Animal Health Risks:

· Livestock and Pet Deaths: Livestock and pets are highly susceptible to microcystin poisoning. In Nebraska in 2004, three dogs died shortly after swimming in and drinking from a lake with an algal bloom, with microcystin confirmed as the cause. Deaths in livestock are often associated with droughts, where animals are forced to drink contaminated water .

· Wildlife Mortality: In 2009, an unprecedented die-off of large mammals in Kruger National Park, South Africa, was linked to Microcystis blooms in dams. Grazers and browsers that drank from accumulated scums were affected, while wading animals like elephants and buffalo were not. The bloom was fueled by nutrients from a resident hippo population . In 2010, sea otters, a threatened species, died from consuming bivalves that had bioaccumulated microcystins to levels 107 times higher than ambient water .

Environmental and Economic Impacts:

· Ecosystem Disruption: Blooms block sunlight, deplete dissolved oxygen upon decomposition (creating "dead zones"), and produce compounds with unpleasant odors .

· Economic Costs: Water treatment costs increase, and recreational areas suffer from beach closures and loss of tourism revenue .

---

6. Detection, Monitoring, and Control

Detection and Monitoring:

· Microscopy: Identification based on colony morphology and cell characteristics.

· Toxin Analysis: Liquid chromatography-mass spectrometry (LC-MS) and enzyme-linked immunosorbent assays (ELISA) are used to quantify microcystins and other cyanotoxins.

· Molecular Methods: PCR amplification of microcystin synthetase genes (mcy) can identify toxin-producing strains.

· Remote Sensing: Satellite imagery can detect and map the extent of surface blooms.

Control Strategies:

· Nutrient Reduction: The most fundamental long-term approach involves reducing phosphorus and nitrogen inputs from agricultural runoff, sewage, and urban stormwater.

· Chemical Methods: Application of hydrogen peroxide or algicides like copper sulfate, though these can cause secondary pollution and cell lysis, releasing toxins .

· Physical Methods: Aeration, mixing of the water column to disrupt buoyancy, and application of phosphorus-binding clays (e.g., red clays) .

· Biological Methods: Use of algicidal bacteria, viruses (cyanophages), or plant-derived metabolites that inhibit cyanobacterial growth . For example, the aquatic plant Myriophyllum spicatum produces polyphenols that inhibit M. aeruginosa .

---

7. Biotechnological Potential and Emerging Research

Pharmaceutical Leads from Microginins:

Microginins represent a significant area of biotechnological interest. Their potent ACE inhibitory activity, with IC50 values as low as 7 µg/mL for some variants, positions them as promising lead compounds for developing new antihypertensive drugs . Different microginin congeners show varying inhibitory activities against leucine aminopeptidase and other proteases, suggesting a range of potential therapeutic applications. The structural diversity of these peptides, with variations in amino acid sequence and chlorination patterns, provides a rich source for drug discovery .

Anticancer, Antioxidant, and Antibacterial Compounds:

Research has demonstrated that secondary metabolites from M. aeruginosa possess significant biological activities. A 2020 study isolated two compounds, benzeneacetanomide and a norvaline derivative, from a bloom sample in India. The mixture of these compounds exhibited antibacterial activity against human pathogens, antioxidant capacity in free radical scavenging assays, and anticancer activity against cancer cell lines, highlighting the potential for developing cancer therapeutics from this cyanobacterium .

Natural Product Synthesis:

M. aeruginosa is also being studied for its ability to naturally produce butylated hydroxytoluene (BHT), an industrial antioxidant widely used as a food additive . This opens possibilities for biotechnological production of valuable chemicals.

Interaction with Glyphosate:

Research has shown that M. aeruginosa can thrive on glyphosate, the active ingredient in the herbicide Roundup, using it as a phosphorus source. This suggests that glyphosate runoff from agriculture may selectively promote cyanobacterial blooms, giving them a competitive advantage over other phytoplankton .

---

8. In-Depth Toxicological and Biotechnological Profile of Microcystis aeruginosa

Introduction

Microcystis aeruginosa occupies a paradoxical position in the scientific landscape. It is simultaneously a notorious agent of ecological and public health crises and a prolific source of chemically diverse and therapeutically promising natural products. As a dominant player in harmful algal blooms worldwide, its production of microcystins poses a clear and present danger to aquatic ecosystems, drinking water supplies, and animal and human health. Yet, the same biochemical machinery that yields these potent toxins also generates a vast array of other bioactive peptides, including microginins, cyanopeptolins, and aeruginosins. The study of this organism is therefore bifurcated: one branch focuses on mitigating its harmful effects, while the other seeks to harness its chemical creativity for pharmaceutical and industrial applications.

1. Microcystins: Structure, Mechanism, and Toxicity

Structure and Variants: Microcystins are monocyclic heptapeptides, characterized by a unique β-amino acid, Adda (3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid), which is critical for their biological activity. Over 250 different microcystin congeners have been identified, varying in their amino acid composition, with microcystin-LR (containing leucine and arginine) being the most prevalent and well-studied.

Mechanism of Toxicity: The primary mechanism of microcystin toxicity is the potent and specific inhibition of serine/threonine protein phosphatases 1 and 2A (PP1 and PP2A) in eukaryotic cells. These enzymes are key regulators of numerous cellular processes, including cytoskeletal structure, cell cycle progression, and apoptosis. Inhibition of PP1 and PP2A leads to hyperphosphorylation of cytoskeletal proteins, causing disruption of hepatocyte structure, leading to intrahepatic hemorrhage, necrosis, and liver failure. This mechanism also underlies their tumor-promoting activity.

Toxicokinetics: Microcystins are water-soluble and enter cells via organic anion transporting polypeptides (OATPs), particularly OATP1B1 and OATP1B3, which are highly expressed in hepatocytes. This explains their specific hepatotoxicity. Once inside the cell, they bind covalently to their target phosphatases. The LD50 of microcystin-LR in rodents is approximately 50-100 µg/kg by intraperitoneal injection.

Human Health Impacts: Acute poisoning in humans manifests as abdominal pain, vomiting, diarrhea, and elevated liver enzymes. Chronic exposure through drinking water is linked to liver damage and an increased incidence of liver cancer. The tragic 1996 Caruaru incident in Brazil, where 60 dialysis patients died after exposure to microcystin-contaminated water, stands as a grim reminder of the potency of these toxins .

2. Microginins: From ACE Inhibition to Pharmaceutical Promise

Discovery and Structural Diversity: First isolated from M. aeruginosa (NIES-100) in 1993, microginins are a growing class of linear pentapeptides characterized by an N-terminal Ahda (3-amino-2-hydroxydecanoic acid) and typically two tyrosine residues at the C-terminus . They exhibit remarkable structural diversity, with over 120 distinct analogues identified to date. Variations occur in the length of the peptide chain (4 to 6 amino acids), the amino acid at position 2, N-methylation patterns, and chlorination of the Ahda residue.

Angiotensin-Converting Enzyme (ACE) Inhibition: The seminal discovery of microginins was driven by their ability to inhibit ACE, a key enzyme in the renin-angiotensin system that regulates blood pressure. ACE inhibitors are a cornerstone of hypertension therapy. The IC50 value for the original microginin was 7.0 µg/mL, demonstrating its potential as a lead for antihypertensive drugs . Subsequent studies have shown that different microginin congeners vary in their ACE inhibitory potency, with some also exhibiting activity against aminopeptidases.

Other Bioactivities: Beyond ACE inhibition, microginins have shown inhibitory activity against leucine aminopeptidase and other aminoproteinases. Some variants have demonstrated eco-cytotoxicity against crustaceans and fish larvae, suggesting a role in chemical defense for the cyanobacterium .

Biotechnological Significance: The chemodiversity of microginins, combined with their specific enzyme inhibitory activities, makes them a valuable resource for drug discovery and development. Their unique structure, particularly the Ahda moiety, offers a novel scaffold for designing enzyme inhibitors.

3. Other Bioactive Metabolites and Therapeutic Potential

Benzeneacetanomide and Norvaline Derivatives: A pivotal 2020 study successfully isolated and characterized two bioactive compounds from M. aeruginosa biomass collected in India: benzeneacetanomide and a norvaline derivative (l-Norvaline, n-propargyloxycarbonyl) . These compounds were tested as a mixture and demonstrated:

· Antibacterial Activity: Efficacy against human clinical bacterial strains, suggesting potential as antimicrobial agents.

· Antioxidant Activity: Ability to scavenge free radicals, indicating potential in combating oxidative stress-related diseases.

· Anticancer Activity: Cytotoxicity against cancer cell lines, pointing towards possible applications in oncology. This study underscores that M. aeruginosa is not merely a source of toxins but also a reservoir of compounds with direct therapeutic potential.

Cyanopeptolins and Aeruginosins: These are other major classes of cyanopeptides produced by M. aeruginosa. Cyanopeptolins are potent inhibitors of serine proteases like trypsin and chymotrypsin, while aeruginosins inhibit thrombin and other trypsin-like enzymes. Such protease inhibitors have applications in treating thrombosis, inflammation, and viral infections.

Lipopolysaccharides (LPS): While primarily considered endotoxins, the LPS of M. aeruginosa also has immunomodulatory properties. Its role in causing skin irritation upon contact is well-documented, but its systemic effects upon ingestion or inhalation warrant further study .

An Integrated View of Microcystis aeruginosa: A Dual-Edged Sword

· For Public and Environmental Health (The Toxic Threat): M. aeruginosa functions as a potent and pervasive environmental hazard. Its blooms degrade water quality, kill aquatic life, and endanger livestock, pets, and humans. The genotoxic potential of its extracts, demonstrated in 2024, adds a new dimension of concern, suggesting that exposure may carry risks beyond acute hepatotoxicity . The stable, water-soluble nature of microcystins makes them a persistent threat to drinking water supplies, necessitating advanced and costly treatment processes. The economic impact on tourism, recreation, and property values in affected regions is substantial. Addressing this threat requires integrated watershed management focused on nutrient reduction, coupled with effective monitoring and, where necessary, bloom control measures.

· For Drug Discovery and Biotechnology (The Chemical Goldmine): Simultaneously, M. aeruginosa functions as a miniature, highly productive chemical factory. Its non-ribosomal peptide synthetase (NRPS) and polyketide synthase (PKS) enzyme complexes generate an astonishing diversity of molecules honed by evolution to interact with biological targets. Microginins offer a direct route to novel ACE inhibitors for hypertension. Cyanopeptolins and aeruginosins provide leads for protease inhibitor drugs with applications in cardiovascular disease, inflammation, and cancer. The discovery of antibacterial, antioxidant, and anticancer activities in simple benzeneacetanomide and norvaline derivatives suggests that even relatively "simple" metabolites from this organism hold therapeutic promise .

Conclusion: Microcystis aeruginosa is a quintessential example of nature's duality, embodying both peril and promise. Its capacity to produce potent hepatotoxins positions it as a major threat to water security and public health, a challenge exacerbated by climate change and continued nutrient pollution. Yet, the very same evolutionary pressures that led to the production of these defensive chemicals have endowed it with a rich and varied secondary metabolism that is now being actively explored for its biotechnological potential. The microginins, with their ACE inhibitory activity, are already validated leads for cardiovascular drug development. The ongoing discovery of novel anticancer, antioxidant, and antibacterial compounds from its biomass continues to expand its therapeutic horizon. As research progresses, the challenge will be to manage the clear and present dangers posed by this organism in the environment while simultaneously unlocking and harnessing its remarkable chemical creativity for the benefit of human health. The story of M. aeruginosa is far from one-dimensional; it is a complex narrative of toxicity, ecology, and pharmaceutical promise, demanding a nuanced and balanced scientific approach.

---

Disclaimer:

Microcystis aeruginosa is a toxin-producing cyanobacterium and poses a serious health risk. Direct contact with or ingestion of water containing M. aeruginosa blooms should be strictly avoided. The information presented here is for educational and scientific purposes only. It is not intended to encourage the handling, cultivation, or use of this organism. Any research involving M. aeruginosa or its toxins must be conducted by trained professionals in appropriate laboratory settings with strict safety protocols. This information is not a substitute for professional environmental or public health guidance.

---

9. Reference Books, Books for In-depth Study:

· Toxic Cyanobacteria in Water: A Guide to Their Public Health Consequences, Monitoring and Management (2nd Edition) by Ingrid Chorus and Martin Welker (eds.), CRC Press, 2021.

· Cyanobacterial Harmful Algal Blooms: State of the Science and Research Needs by H. Kenneth Hudnell (ed.), Springer, 2008.

· Handbook of Cyanobacterial Monitoring and Cyanotoxin Analysis by Jussi Meriluoto, Lisa Spoof, and Geoffrey A. Codd (eds.), Wiley, 2017.

· The Cyanobacteria: Molecular Biology, Genomics and Evolution by Antonia Herrero and Enrique Flores (eds.), Caister Academic Press, 2008.

---

10. Further Study: Organisms That Might Interest You Due to Similar Properties

1. Aphanizomenon flos-aquae

· Species: Aphanizomenon flos-aquae | Family: Aphanizomenonaceae | Phylum: Cyanobacteria

· Similarities: A common bloom-forming cyanobacterium often co-occurring with Microcystis. It produces different cyanotoxins, including the neurotoxin anatoxin-a and cylindrospermopsin, illustrating the diversity of toxins within the cyanobacterial phylum. It is also harvested commercially as a dietary supplement (Klamath Lake AFA), highlighting the importance of strain-specific toxicity .

2. Planktothrix rubescens

· Species: Planktothrix rubescens | Family: Phormidiaceae | Phylum: Cyanobacteria

· Similarities: A filamentous cyanobacterium that produces microcystins and forms deep water blooms in lakes. It serves as another example of a microcystin-producing genus with significant ecological impact.

3. Nodularia spumigena

· Species: Nodularia spumigena | Family: Aphanizomenonaceae | Phylum: Cyanobacteria

· Similarities: Produces nodularin, a cyclic pentapeptide hepatotoxin very similar in structure and mechanism to microcystin. It is the dominant toxic cyanobacterium in the Baltic Sea, forming massive blooms and demonstrating the marine relevance of this toxin class.

4. Streptomyces species

· Species: Various, e.g., Streptomyces griseus | Family: Streptomycetaceae | Phylum: Actinomycetota

· Similarities: Like Microcystis, Actinobacteria, particularly the genus Streptomyces, are renowned for their prolific production of secondary metabolites, including over two-thirds of clinically used antibiotics. Both are prokaryotic organisms with complex genomes encoding numerous NRPS and PKS pathways, making them microbial factories for bioactive natural products.

---

-x-x-x-End-x-x-x-